Delivery Order SPE2DB20D1100-SPE2DB25FC4F7

Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S medical supplies. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $5,055.04 and an ultimate completion date of May 2, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The...
This federal contract award, valued at $49,993.00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a pharmaceutical product, with an ultimate completion date of September 20, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a neurological medication, with a ceiling value of $28,649.02. The contract is a firm fixed-price delivery order, with a performance period ending on May 6, 2025. This contract is not designated as a set-aside and was likely competed openly. AmerisourceBergen Drug Corp holds a...
This federal contract award (SPE2DB22D3016|SPE2DB25FAAQ2) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S. The contract has a ceiling value of $65,226.74 and an ultimate completion date of October 16, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S. The contract has a ceiling value of $40,665.30 and a completion date of December 12, 2024. It is a firm fixed-price contract, which means the price will not change regardless of the contractor's costs. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of Fingolimod 0.5 mg capsules to the Defense Logistics Agency (DLA). The $51,351.06 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 2, 2023, with a completion date of May 3, 2023. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of...
This federal contract award, with ID SPE2DB24D1104|SPE2DB25FXUN0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide FINGOLIMOD 0.5 MG CAPSULE 30S. The contract is a Delivery Order with a Firm Fixed Price of $27,491.97 and an ultimate completion date of November 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of fingolimod 0.5 milligram capsules. The award, valued at $11,235.03, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply Fingolimod 0.5 mg capsules. The contract has a firm-fixed price of $2,823.25 and a period of performance through July 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is for the delivery of Fingolimod 0.5 mg capsules. The contract, valued at $12,806.49, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC4F7
    Delivery Order

This federal contract award is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $3,596.00 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded on May 20, 2025, with a completion date of May 21, 2025. Amerisourcebergen Drug Corp also holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026.

Generated 8/24/25, 12:44 AM